Q2 2026 Holdings
Filed 2026-08-14 | 32 holdings | $158.4M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Cogent Biosciences Inc(COGT) | COM | 19240Q201 | $13.3M | 343,284 | 8.4% |
| Axsome Therapeutics Inc.(AXSM) | COM | 05464T104 | $13.2M | 53,916 | 8.3% |
| Genmab A/S(GMAB) | SPONSORED ADS | 372303206 | $11.8M | 430,600 | 7.5% |
| Celldex Therapeutics Inc New(CLDX) | COM NEW | 15117B202 | $10.7M | 287,583 | 6.8% |
| Trevi Therapeutics Inc(TRVI) | COM | 89532M101 | $9.8M | 524,224 | 6.2% |
| Revolution Medicines Inc(RVMD) | COM | 76155X100 | $9.6M | 51,053 | 6.0% |
| Definium Therapeutics Inc(DFTX) | COM SHS | 24477V105 | $8.9M | 188,282 | 5.6% |
| VIR Biotechnology Inc(VIR) | COM | 92764N102 | $8.7M | 853,685 | 5.5% |
| Immunovant Inc(IMVT) | COM | 45258J102 | $8.0M | 208,368 | 5.1% |
| Urogen Pharma LTD(URGN) | COM | M96088105 | $7.0M | 191,313 | 4.4% |
| Climb BIO Inc(CLYM) | COM | 28658R106 | $6.8M | 521,082 | 4.3% |
| Adlai Nortye LTD(ANL) | SPONSORED ADS | 00704R109 | $6.4M | 552,501 | 4.0% |
| Savara Inc(SVRA) | COM | 805111101 | $6.0M | 977,460 | 3.8% |
| Maplight Therapeutics Inc(MPLT) | COM | 56565P103 | $4.5M | 125,432 | 2.8% |
| Oric Pharmaceuticals Inc(ORIC) | COM | 68622P109 | $4.4M | 406,077 | 2.8% |
| United Therapeutics Corp del(UTHR) | COM | 91307C102 | $3.9M | 7,172 | 2.5% |
| Vaxcyte Inc(PCVX) | COM | 92243G108 | $3.9M | 66,793 | 2.5% |
| Beone Medicines LTD(ONC) | SPONSORED ADS | 07725L102 | $3.5M | 12,273 | 2.2% |
| Cabaletta BIO Inc(CABA) | COM | 12674W109 | $3.5M | 1,278,652 | 2.2% |
| ZAI LAB LTD(ZLAB) | ADR | 98887Q104 | $3.0M | 155,813 | 1.9% |
| Sionna Therapeutics Inc(SION) | COM | 829401108 | $2.8M | 63,156 | 1.8% |
| Bright Minds Biosciences Inc(DRUG) | COM NEW | 10919W405 | $2.1M | 30,456 | 1.3% |
| Aclaris Therapeutics Inc(ACRS) | COM | 00461U105 | $1.4M | 257,675 | 0.9% |
| Cybin Inc(HELP) | COM NEW | 23256X407 | $1.4M | 204,424 | 0.9% |
| Kiniksa Pharmaceuticals Intl(KNSA) | ORD SHS CL A | G52694109 | $1.2M | 18,867 | 0.8% |
| Roivant Sciences LTD(ROIV) | SHS | G76279101 | $906.8K | 25,623 | 0.6% |
| Tonix Pharmaceuticals Hldg C(TNXP) | COM NEW | 890260839 | $812.1K | 63,648 | 0.5% |
| Protara Therapeutics Inc(TARA) | COM STK | 74365U107 | $464.0K | 121,457 | 0.3% |
| Faeth Therapeutics Inc(SNSE) | COM NEW | 81728A207 | $354.4K | 14,175 | 0.2% |
| Boundless BIO Inc(BOLD) | COM | 10170A100 | $138.4K | 55,356 | 0.1% |
| Biomea Fusion Inc(BMEA) | COM | 09077A106 | $85.3K | 250,000 | 0.1% |
| Vyne Therapeutics Inc(VYNE) | COM | 92941V308 | $39.9K | 61,269 | 0.0% |